Biopharmaceutical Companies

 
Stock Quotes for Biopharmaceutical Companies top ^
  • Industry: Biotechnology
  • Sector: Healthcare
  • Stock Style: Small Growth
  • Stock Type: Distressed
Sign-up for kerx investment picks
  • Industry: Medical Devices
  • Sector: Healthcare
  • Stock Style: Small Growth
  • Stock Type: Distressed
Sign-up for navb investment picks
  • Industry: Biotechnology
  • Sector: Healthcare
  • Stock Type: Distressed
Sign-up for rgrx investment picks
  • Industry: Drug Manufacturers - Major
  • Sector: Healthcare
  • Stock Style: Small Growth
  • Stock Type: Distressed
Sign-up for kyth investment picks
  • Industry: Biotechnology
  • Sector: Healthcare
  • Stock Style: Small Growth
  • Stock Type: Speculative Growth
Sign-up for rgrx investment picks
  • Industry: Medical Devices
  • Sector: Healthcare
  • Stock Style: Small Growth
  • Stock Type: Distressed
Sign-up for navb investment picks
  • Industry: Drug Manufacturers - Major
  • Sector: Healthcare
  • Stock Style: Small Growth
  • Stock Type: Distressed
Sign-up for kyth investment picks
  • Industry: Drug Manufacturers - Specialty & Generic
  • Sector: Healthcare
  • Stock Style: Small Core
  • Stock Type: Distressed
Sign-up for pvct investment picks
  • Industry: Biotechnology
  • Sector: Healthcare
  • Stock Type: Distressed
Sign-up for abpi investment picks
  • Industry: Drug Manufacturers - Major
  • Sector: Healthcare
  • Stock Style: Small Value
Sign-up for 003060 investment picks
  • Industry: Drug Manufacturers - Major
  • Sector: Healthcare
  • Stock Style: Small Value
Sign-up for 08019 investment picks
  • Industry: Biotechnology
  • Sector: Healthcare
  • Stock Style: Large Growth
Sign-up for 01177 investment picks

 
News Articles for Biopharmaceutical Companies top ^
2014/9/12
Recognizing the critical role that emerging biopharmaceutical companies play in the global marketplace, Quintiles today expanded its solution set with the launch of the Quintiles Emerging Biopharma Solution – a new offering designed to meet the unique clinical development needs and goals of these companies.
Sign-up for Quintiles Launches New Customer Solution to Meet the Unique Needs of Emerging Biopharmaceutical Companies investment picks
BOTHELL, Wash., July 29, 2014 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. ("Alder") (Nasdaq:ALDR) , a clinical-stage biopharmaceutical company developing monoclonal antibody therapeutics for the treatment of migraine, autoimmune and inflammatory diseases, today announced that it will report its second quarter 2014 financial and operating results after the close of U.S. financial markets on Tuesday, August 5, 2014.
Sign-up for Alder BioPharmaceuticals to Host Conference Call to Discuss Second Quarter 2014 Financial and Operating Results investment picks
2014/9/2
HERZLIYA, Israel , Sept.
Sign-up for XTL Biopharmaceuticals Provides Financial and Operational Update for the Second Quarter of 2014 investment picks
CALABASAS, Calif., July 10, 2014 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced that its New Drug Application (NDA) for ATX-101 (deoxycholic acid), has been accepted for filing by the U.S. Food and Drug Administration (FDA). The acceptance of the NDA reflects the FDA's determination that the application is sufficiently complete to permit a substantive review.
Sign-up for KYTHERA Biopharmaceuticals Announces FDA Acceptance of ATX-101 New Drug Application investment picks
BOTHELL, Wash., Aug.
Sign-up for Alder BioPharmaceuticals Reports Second Quarter 2014 Financial and Operating Results investment picks
WESTLAKE VILLAGE, Calif., July 31, 2014 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced it will release its second quarter 2014 operating results and will host an investor call and webcast at 4:30 p.m. ET on Thursday, August 7, 2014.
Sign-up for KYTHERA Biopharmaceuticals to Release Second Quarter 2014 Operating Results investment picks
PRINCETON, N.J. , Sept.
Sign-up for Soligenix Appoints Rasappa Arumugham, PhD, as Vice President of Biopharmaceutical Development investment picks

Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Biopharmaceutical Companies
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Biopharma Companies  |  Next: Biopharmaceutical Research